Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug DiscoveryAbsci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery GlobeNewswire
||
Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics... 
Ranchero Completes Debt Settlement TransactionRanchero Completes Debt Settlement Transaction GlobeNewswire
||
VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) — Ranchero Gold Corp. (“Ranchero” or the “Company”) (TSX.V:RNCH) is pleased to announce that, further to its press release dated November... 
Churchill Downs Incorporated 2024 Fourth Quarter and Full Year Financial Results Conference Call InvitationChurchill Downs Incorporated 2024 Fourth Quarter and Full Year Financial Results Conference Call Invitation GlobeNewswire
||
LOUISVILLE, Ky., Jan. 10, 2025 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release fourth quarter and full year 2024 financial... 
Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business UnitY-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit GlobeNewswire
||
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel... 
Golconda Gold Ltd. Announces Appointment of Vikram Kapoor to Board and Equity GrantsGolconda Gold Ltd. Announces Appointment of Vikram Kapoor to Board and Equity Grants GlobeNewswire
||
TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce that Mr. Vikram Kapoor has been... 
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceRoyalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire
||
2024 Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with potential for peak royalties of >$1.2 billion; multiple key upcoming... 
Net Asset Value(s)Net Asset Value(s) GlobeNewswire
||
WisdomTree Issuer plc – Daily Fund Prices 9-January-25 WisdomTree Battery Solutions UCITS ETF – USD Acc09/01/2025IE00BKLF1R755029258USD150,270,611.6729.8793WisdomTree BioRevolution UCITS ETF – USD ACC09/01/2025IE000O8KMPM1222000USD3,578,376.6616.1188WisdomTree Emerging Markets Equity Income UCITS ETF09/01/2025IE00BQQ3Q0679074862USD129,576,620.9614.2786WisdomTree Emerging... 
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi SequencingPacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing GlobeNewswire
||
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and... 
C4 Launches KOL Incubation School to Empower the Next Generation of Crypto Content CreatorsC4 Launches KOL Incubation School to Empower the Next Generation of Crypto Content Creators GlobeNewswire
||
DUBAI, United Arab Emirates, Jan. 10, 2025 (GLOBE NEWSWIRE) — The Crypto Content Creator Campus (C4), announces the launch of its C4 KOL Incubation School, a premier program designed... 
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660) GlobeNewswire
||
Conference call to discuss positive initial Phase 1 clinical data today at 8:30 a.m. ET CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a...